Ronen Luzon (MYSZ) Interviewed on ILTV With Emanuelle Kadosh.
LOOKING FOR AN APP TO SOLVE YOUR ONLINE SHOPPING PROBLEMS?
What if I told you - you no longer...
Internet Stock Review Adds MySize (MYSZ) $0.45 to Watch List.
Short Term Turbulence Creates Potential Entry Point at $0.45.
Investors appeared to react...
Forget Global Warming. Worry About Global Click Farms.
Some farms have 17,000 phones ready to 'auto-click' on any click on anything you want. Fake views, fake reviews - you want...
A New Stock Exchange for Israeli Tech Companies, Backed by NYSE.
With Toronto Grabbing Some of the Best Israeli Tech Listings Away From NASDAQ, We Saw This Coming.
From...
Duos Technologies (DOUT) $0.70. Artificial Intelligence Made Easy. Grossly Undervalued.
Internet Stock Review Adds Duos Technologies ($0.70) to Watch List. Graduates to OTCQX 6/20/19.
Duos Technologies Website. Presentation...
MySize (MYSZ) CEO Ron Luzon. Interview. (Bloomberg)
AIRPORT CITY, Israel, June 27, 2019 /PRNewswire/ -- My Size, Inc. (the "Company" or "My Size") (MYSZ) (MYSZ), the developer and creator of smartphone measurement solutions,...
Biotech Stock Review Adds NanoVibronix (NAOV) $2.95, to Watch List.
NanoVibronix Announces Closing of $3.2 Million Private Placement to Existing Shareholders.
Adding to Watch List @ $2.95*...
Israeli Tech Stocks Raise $165 Million on Toronto TSX, Bypassing NASDAQ.
Toronto Stock Exchange woos firms as race for Israeli tech listings grows (Times of Israel).
Yossi Boker, head...
Baltimore’s $10 Million Problem is Just the Tip of the Iceberg.
Some countries smartest and most ruthless computer engineers are faced with a career choice, join the Black hat hacking Company which had...
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
